Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma (Q34743450)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma |
scientific article |
Statements
1 reference
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma (English)
1 reference
Alexander M M Eggermont
1 reference
Stefan Suciu
1 reference
Ulrich Keilholz
1 reference
Michele Maio
1 reference
Wim H J Kruit
1 reference
Brigitte Dreno
1 reference
Laurent Mortier
1 reference
Vanna Chiarion-Sileni
1 reference
Alessandro Testori
1 reference
Thierry Dorval
1 reference
Jean-Jacques Grob
1 reference
Juergen C Becker
1 reference
Alan Spatz
1 reference
Jamila Louahed
1 reference
Frédéric F Lehmann
1 reference
Vincent G Brichard
1 reference
1 reference
Identifiers
1 reference